Trial intelligence / Profile preview

Nano-hydroxyapatite vs Potassium Nitrate for MIH Hypersensitivity

NCT06896565Not yet recruiting

Sponsor
Cairo University
Start
Jun 2025
Primary completion
Aug 2025
Modality
Nanoparticles, Device-based Delivery, DNA Intercalators/Alkylators
01

Overview

Randomised trial of nanohydroxyapatite and potassium nitrate in Molar incisor hypomineralization (MIH) (3 arms), sponsored by Cairo University. Primary endpoint: Dentin Hypersensitivity. Planned start Jun 2025; status: not yet recruiting.

02

Drugs

nanohydroxyapatitepotassium nitrate
03

Conditions

Molar incisor hypomineralization (MIH)

Beyond the preview

Go deeper on NCT06896565.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06896565.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call